MRNA Sep 2024 90.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:24AM EDT. Market open.
| Previous Close | 0.6200 |
| Open | 0.6900 |
| Bid | 0.3500 |
| Ask | 0.9200 |
| Strike | 90.00 |
| Expire Date | 2024-09-20 |
| Day's Range | 0.6900 - 0.6900 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 337 |
ACCESSWIREModerna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older Higher efficacy was observed in mRNA-1283 compared ...
Investor's Business DailyIs Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Moderna stock is trading sideways despite a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?
Yahoo FinanceModerna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Moderna revealed its combination flu/COVID vaccine performed better than the two shots independently.
© 2024 Yahoo. All rights reserved.